What Crispr Therapeutics, Inc. pays H-1B Research Associates

Crispr Therapeutics, Inc. filed 10 certified H-1B LCAs for Research Associate roles in FY2025-FY2026. In FY2026 (October to June), the middle half of its 5 filings stated $102,000 to $120,000 a year, with a median of $105,844.

Median, FY2026 so far$105,844
Middle half$102,000 to $120,000
Certified LCAs, FY2025-FY202610

By fiscal year

YearLCAsMedianMiddle halfLowest to highestPrevailing wage
FY2026 so far5$105,844$102,000 to $120,000$92,000 to $123,838$101,026
FY20255$107,174$95,862 to $109,158$93,787 to $127,077$107,099

Prevailing wage is the median of the DOL prevailing wage on the same filings: the floor the law sets for that job and place.

By prevailing-wage level

LevelLCAsMedianMiddle half
Level I (entry)1$95,862too few
Level II (qualified)8$108,166$104,883 to $120,960
Level IV (fully competent)1$92,000too few

Level I is entry and Level IV is fully competent, as the employer classified the position. Seniority words in the job title are folded into one title here; the level is where seniority shows.

By worksite

WorksiteLCAsMedianLowest to highest
Boston, MA8$106,509$92,000 to $123,838
South San Francisco, CA1$127,077$127,077

Titles grouped here

Filed as Biochemists and Biophysicists (SOC 19-1021).

Applying to Crispr Therapeutics, Inc.?

Nyanza puts these filings next to any Research Associate posting you check, so you know what the employer has stated before the first call.